[Federal Register Volume 63, Number 29 (Thursday, February 12, 1998)]
[Notices]
[Page 7182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-3610]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that Roche Diagnostic Systems, Inc., 
1080 U.S. Highway 202, Somerville, New Jersey 08876-3771, made 
application to the Drug Enforcement Administration (DEA) by letter 
dated December 17, 1997, for registration as a bulk manufacturer of 
ecgonine (9180), a basic class of controlled substance listed in 
Schedule II.
    The firm plans to manufacture small quantities of ecgonine which 
will be further converted into derivatives for incorporation in drug of 
abuse detection kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 13, 1998.

    Dated: January 21, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-3610 Filed 2-11-98; 8:45 am]
BILLING CODE 4410-09-M